Nutex Health (NASDAQ:NUTX) Cut to Hold at Wall Street Zen

Wall Street Zen lowered shares of Nutex Health (NASDAQ:NUTX) from a buy rating to a hold rating in a research report released on Saturday morning,Wall Street Zen reports.

Other research analysts also recently issued research reports about the company. LADENBURG THALM/SH SH began coverage on Nutex Health in a research note on Monday, October 26th. They issued a “buy” rating and a $336.00 price objective on the stock. Zacks Research cut Nutex Health from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 6th. Weiss Ratings upgraded Nutex Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Tuesday, October 6th. B. Riley Financial reiterated a “buy” rating on shares of Nutex Health in a research note on Friday, September 4th. Finally, Lake Street Capital reissued a “buy” rating and issued a $310.00 target price (up from $235.00) on shares of Nutex Health in a report on Tuesday, August 11th. Four investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, Nutex Health has a consensus rating of “Moderate Buy” and a consensus target price of $323.67.

Nutex Health Trading Down 7.3%

NASDAQ:NUTX opened at $185.60 on Friday. Nutex Health has a one year low of $83.99 and a one year high of $226.16. The business has a fifty day moving average price of $203.24 and a 200-day moving average price of $150.77. The firm has a market capitalization of $1.27 billion, a price-to-earnings ratio of 8.35 and a beta of 0.55. The company has a debt-to-equity ratio of 0.59, a current ratio of 5.00 and a quick ratio of 4.96.

Nutex Health (NASDAQ:NUTX) last released its earnings results on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, beating the consensus estimate of $4.95 by $4.43. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%. The company had revenue of $210.75 million for the quarter, compared to the consensus estimate of $215.03 million. Sell-side analysts forecast that Nutex Health will post 26.65 EPS for the current year.

Insider Buying and Selling at Nutex Health

In related news, Director Scott Saunders sold 203 shares of the company’s stock in a transaction on Friday, September 18th. The shares were sold at an average price of $214.25, for a total value of $43,492.75. Following the completion of the transaction, the director owned 400 shares of the company’s stock, valued at approximately $85,700. This represents a 33.67% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 44.68% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Kilter Group LLC bought a new position in shares of Nutex Health during the 2nd quarter valued at approximately $27,000. Allworth Financial LP bought a new stake in Nutex Health in the second quarter worth $35,000. GK Wealth Management LLC purchased a new stake in Nutex Health during the third quarter valued at $73,000. EverSource Wealth Advisors LLC purchased a new stake in Nutex Health during the first quarter valued at $83,000. Finally, State of Alaska Department of Revenue raised its stake in Nutex Health by 243.6% during the third quarter. State of Alaska Department of Revenue now owns 1,000 shares of the company’s stock valued at $211,000 after purchasing an additional 709 shares in the last quarter. Institutional investors own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, medical facilities and physician practices in the United States. The company focuses on providing convenient, community-based care through its micro-hospitals and other healthcare locations.

Its hospital operations generally include emergency services, inpatient care, diagnostic testing and outpatient treatment. Nutex also operates physician networks and supports primary care and specialty providers.